Overview

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
1. To determine the outcome of patients with potentially resectable superior sulcus tumors of non-small cell histology treated by surgery followed by accelerated radiation therapy and chemotherapy. 2. To evaluate toxicity, the initial local-regional control rate, sites of and time to local and distant failures.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Cisplatin
Etoposide
Etoposide phosphate